Pharmacology
All Targets
7-TM Receptors
Ion Channels
Nuclear Receptors
Enzyme-Linked Receptors
Transporters
Enzymes
Other Pharmacology
Cellular Processes
Angiogenesis
Apoptosis
Cell Cycle
Cell Metabolism
Cytoskeleton & Motor Proteins
ECM & Adhesion Molecules
Signal Transduction
Stem Cells
Product Type
All Products
New Products
Small Molecules
Peptides
Antibodies
Jena Bioscience
Controlled Substances
Toxins
Caged Compounds
Fluorescent Probes
Screening Libraries
Ligand Sets
Other Product Types
Research Area
Cancer
Cardiovascular Disease
Endocrinology
Immunology
Metabolic Disease
Neurological Disease
Pain & Inflammation
Respiratory Disease
OxaliplatinCat No. 2623 |
Price and Availability |
|
Alternative Name: Eloxatin Chemical Name: Oxalato[(1R-trans)-1,2-cyclohexanediamine]platinum(II) |
|
Biological Activity
Antitumor agent that forms platinum-DNA adducts. Causes intra- and interstrand DNA crosslinks blocking DNA replication and transcription. Displays higher cytotoxicity and lower nephrotoxicity than analog cisplatin (Cat. No. 2251) and shows antitumor activity in cell lines with acquired cisplatin resistance.Technical Data
M.Wt:397.29
Formula:C8H14N2O4Pt
Solubility:Soluble to 10 mM in water and to 50 mM in DMSO
Purity: >99 %
Storage:Store at +4°C
CAS No:[61825-94-3]
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
Certificate of Analysis: View current batch
For specific/earlier batch please select:
Material Safety Data Sheet: View current batch
For specific/earlier batch please select:
References
Culy et al (2000) Oxaliplatin. A review of its pharmacological properties and clinical efficacy in metastatic colorectal cancer and its potential in other malignancies. Drugs 60 895. Raymond et al (2002) Cellular and molecular pharmacology of oxaliplatin. Mol.Cancer Ther. 1 227. Mani et al (2002) Oxaliplatin: a review of evolving concepts. Cancer Invest. 20 246.If you know of a useful citation for this product please let us know.
View Related Products by Target
Keywords: Oxaliplatin, DNA, cross-linking, antitumor, agent, inhibitors, synthesis, Apoptosis, Inducers, platinum-DNA, adducts
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
AT 101
Downregulates Bcl-2 and Mcl-1; pro-apoptotic
Betulinic acidAntitumor and anti-HIV agent; activates NF-κB. Also TGR5 agonist
Muristerone AStimulates Bcl-XL mRNA transcription; antiapoptotic
Sign-up for new product e-alerts
New Product Guide
Highlights over 250 new products added in 2009/10. Request a copy or view PDF today.




